Bellevue Life Sciences Acquisition Corp.
Bellevue Life Sciences Acquisition Corp. (BLAC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
blac · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Bellevue Life Sciences Acquisition Corp. (BLAC) measures how much investors pay for each dollar of the company's trailing earnings. BLAC's current PE ratio of N/A is calculated by dividing its stock price of $3.01 by its TTM earnings per share of -$3.08.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2020 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Shell Companies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Bellevue Life Sciences Acquisition Corp.You BLAC | $7M | N/A | — | -$3.08 |
 ATIF Holdings Ltd. ATIF | $8M | N/A | — | -$0.31 |
 Bannix Acquisition Corp. BNIX | $8M | N/A | — | -$0.22 |
 Brilliant Acquisition Corporation BRLI | $9M | 0.50x | -96.5% | $9.39 |
 Cetus Capital Acquisition Corp. CETU | $9M | N/A | — | — |
 EON Resources Inc. EONR | $29M | N/A | — | -$1.58 |
 JV SPAC Acquisition Corp. Class A Ordinary Share JVSA | $28M | 28.03x | +96.5% | $0.37 |
Industry Average 2 peers with valid PE | — | 14.27x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $0.00 | — | |
2024-12-31 FY2024 | — | $-0.54 | — | |
2023-12-31 FY2023 | 199.92x | $0.05 | — | |
2022-12-31 FY2022 | — | $-0.00 | — | |
2021-12-31 FY2021 | — | $-0.00 | — | |
2020-12-31 FY2020 | — | $-0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Bellevue Life Sciences Acquisition Corp. (BLAC) measures how much investors pay for each dollar of the company's trailing earnings. BLAC's current PE ratio of N/A is calculated by dividing its stock price of $3.01 by its TTM earnings per share of -$3.08.
Frequently asked questions
BLAC pe ratio · 6 questionsBLAC's current PE ratio is N/A as of 2026-06-08, based on a stock price of $3.01 and TTM EPS of -$3.08. Data sourced from Financial Modeling Prep via BLAC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Bellevue Life Sciences Acquisition Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08